UBS’s Ambev ABEV Stock Holding History

UBS’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-110,800	Closed	-$780K	–	10304
2014 Q2	$780K	Buy	+110,800	New	+$815K	﹤0.01%	3788

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GTP

Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS's ABEV Position: Q3 2014 in Review

UBS reduced its Ambev (ABEV) stake by 8.8% in Q3 2014, selling an estimated $985K and leaving 1,454,312 shares worth $9.53M. The position accounts for 0.01% of the portfolio, ranked #1487.

UBS first reported a position in ABEV in Q4 2013 and has held it in 4 quarters since. The position peaked at $12.6M in Q4 2013. 312 funds tracked by Wall St. Rank hold ABEV as of Q3 2014.

UBS held 1,454,312 shares of Ambev worth $9.53M as of Q3 2014.
UBS sold 139,834 Ambev shares in Q3 2014, an estimated $985K.
Ambev made up 0.01% of UBS's portfolio in Q3 2014, its #1487 holding.
UBS first reported a position in Ambev in Q4 2013 and has held it in 4 quarters since.
UBS's Ambev position peaked at $12.6M in Q4 2013.
312 funds tracked by Wall St. Rank held Ambev as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.